The Monoamine Oxidase-B Inhibitor Selegiline Does Not Affect 18 F-Florzolotau Uptake in Patients with Progressive Supranuclear Palsy: A Longitudinal Case Series [0.03%]
单胺氧化酶B抑制剂司来吉兰不影响进行性核上性瘫患者氟卓硫酸tau摄取：一项纵向病例系列研究
Xin-Yi Li,Fang-Yang Jiao,Rui-Xin Yao et al.
Xin-Yi Li et al.
Potential Pitfalls of Remote and Automated Video Assessments of Movements Disorders [0.03%]
远程和自动化视频评估运动障碍的潜在问题
Kye Won Park,Hsin Jui Wu,Tianze Yu et al.
Kye Won Park et al.
Bradykinesia in Neurodegenerative Disorders: A Blinded Video Analysis of Pathology-Proven Cases [0.03%]
神经退行性疾病的运动迟缓：病理证实病例的盲法视频分析
Luca Marsili,Kevin R Duque,Nathan Gregor et al.
Luca Marsili et al.
Background: Bradykinesia is a cardinal feature in parkinsonisms. No study has assessed the differential features of bradykinesia in patients with pathology-proven synucleinopathies and tauopathies. ...
The Gaps and Prospects of Movement Disorders Education and Research in Africa: A Continental Survey [0.03%]
非洲运动障碍教育和研究的缺口与前景：一项大陆调查
Eman Hamid,Kigocha Okengo,Biniyam A Ayele et al.
Eman Hamid et al.
Evolution of Clinical Outcome Measures and Biomarkers in Sporadic Adult-Onset Degenerative Ataxia [0.03%]
散发性成人起病的变性共济失调的临床结局指标及生物标记物的演变
Demet Oender,Jennifer Faber,Carlo Wilke et al.
Demet Oender et al.
Background: Sporadic adult-onset ataxias without known genetic or acquired cause are subdivided into multiple system atrophy of cerebellar type (MSA-C) and sporadic adult-onset ataxia of unknown etiology (SAOA). ...
First Clinical Report on the Treatment of Parkinson's Disease with Fetal Midbrain Precursor Cells [0.03%]
胎儿脑中胚层前体细胞治疗帕金森病的首次临床报告
Joopyoung Kim,Han Inbo,Hyun Sook Kim et al.
Joopyoung Kim et al.
Background: Because human fetal ventral mesencephalic tissue grafts provide promising results in ameliorating Parkinson's disease-implicated motor dysfunctions, human fetal midbrain-derived dopamine neuronal precursor cel...
Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort [0.03%]
拥抱单基因帕金森病：MJFF全球遗传性PD队列
Eva-Juliane Vollstedt,Susen Schaake,Katja Lohmann et al.
Eva-Juliane Vollstedt et al.
Background: As gene-targeted therapies are increasingly being developed for Parkinson's disease (PD), identifying and characterizing carriers of specific genetic pathogenic variants is imperative. Only a small fraction of...
Integrated Multi-Cohort Analysis of the Parkinson's Disease Gut Metagenome [0.03%]
帕金森病肠道元基因组的综合多队列分析
Joseph C Boktor,Gil Sharon,Leo A Verhagen Metman et al.
Joseph C Boktor et al.
Background: The gut microbiome is altered in several neurologic disorders, including Parkinson's disease (PD). Objectives: The aim is t...
MDSGene: Extending the List of Isolated Dystonia Genes by VPS16, EIF2AK2, and AOPEP [0.03%]
MDSGene：通过VPS16，EIF2AK2和AOPEP扩展孤立性肌张力障碍基因列表
Mirja Thomsen,Lara M Lange,Christine Klein et al.
Mirja Thomsen et al.
Nahid Olfati,Hamidreza Ghodsi,Ece Bayram et al.
Nahid Olfati et al.